Bliss GVS Pharma Ltd.
| BSE: 506197 | Sector: Health care |
| NSE: BLISSGVS | ISIN Code: INE416D01022 |
| BSE 00:00 | 23 Sep | 79.55 |
-1.45 (-1.79%) |
OPEN
82.85 |
HIGH
83.25 |
LOW
78.10 |
| NSE 00:00 | 23 Sep | 79.40 |
-1.45 (-1.79%) |
OPEN
80.10 |
HIGH
83.70 |
LOW
78.00 |
| OPEN | 82.85 |
| PREVIOUS CLOSE | 81.00 |
| VOLUME | 13525 |
| 52-Week high | 118.90 |
| 52-Week low | 66.25 |
| P/E | 8.82 |
| Mkt Cap.(Rs cr) | 827 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bliss GVS Pharma Ltd. (BLISSGVS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 920.80 | 13.85 | 1.53 | 15585.98 |
| Dr Reddy's Labs | 4139.50 | -43.35 | -1.04 | 14405.20 |
| Cipla | 1067.80 | 6.10 | 0.57 | 13091.79 |
| Lupin | 648.45 | -14.80 | -2.23 | 11771.67 |
| Aurobindo Pharma | 517.45 | -3.05 | -0.59 | 11287.14 |
| Divi's Lab. | 3641.90 | 61.40 | 1.71 | 8879.82 |
| Alkem Lab | 3258.80 | -16.25 | -0.50 | 8829.81 |
| Glenmark Pharma. | 384.35 | -3.70 | -0.95 | 8141.58 |
| Zydus Lifesci. | 356.50 | -6.45 | -1.78 | 7981.90 |
| Torrent Pharma. | 1515.30 | -23.85 | -1.55 | 6742.32 |
| Apollo Hospitals | 4421.20 | -186.25 | -4.04 | 6098.30 |
| Ipca Labs. | 873.85 | -3.40 | -0.39 | 5399.36 |
| Alembic Pharma | 608.95 | -1.70 | -0.28 | 5035.41 |
| Abbott India | 17854.75 | -56.40 | -0.31 | 4919.27 |
| Laurus Labs | 510.50 | -10.60 | -2.03 | 4707.04 |
| Gland Pharma | 2148.15 | -25.00 | -1.15 | 4400.71 |
| Granules India | 323.35 | -1.55 | -0.48 | 3238.44 |
| Glaxosmi. Pharma | 1404.20 | -16.50 | -1.16 | 3217.51 |
| Ajanta Pharma | 1267.55 | -4.35 | -0.34 | 3140.64 |
| Sanofi India | 5904.80 | -48.20 | -0.81 | 2956.60 |
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
